9Perachon S, Schwartz JC, Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine DI, D2 and D3 receptors [ J ]. Eur J Pharmacol, 1999,366 (2-3) :293-300.
10Uslu B, Ozkan SA. Electrommlytical characteristics of piribedil and its differential pulse and square wave vohammetric determination in pharmaceuticals and human serum[J]. J Pharm Biomed Anal,2003, 31 (3) :481-489.